• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质液通过诱导多药耐药蛋白在三维微流控胰腺导管腺癌模型中再现吉西他滨化疗耐药性。

Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins.

机构信息

Mimetas BV, J.H. Oortweg 19, 2333 CH Leiden, The Netherlands.

Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.

出版信息

Int J Mol Sci. 2019 Sep 19;20(18):4647. doi: 10.3390/ijms20184647.

DOI:10.3390/ijms20184647
PMID:31546820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6770899/
Abstract

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here, we demonstrated a 3D microfluidic interstitial flow model to mimic the intratumoral pressure in PDAC. We found that subjecting the S2-028 PDAC cell line to interstitial flow inhibits the proliferation, while maintaining a high viability. We observed increased gemcitabine chemoresistance, with an almost nine-fold higher EC50 as compared to a monolayer culture (31 nM versus 277 nM), and an alleviated expression and function of the multidrug resistance protein (MRP) family. In conclusion, we developed a 3D cell culture modality for studying intratissue pressure and flow that exhibits more predictive capabilities than conventional 2D cell culture and is less time-consuming, and more scalable and accessible than animal models. This increase in microphysiological relevance might support improved efficiency in the drug development pipeline.

摘要

胰腺导管腺癌 (PDAC) 是最致命的癌症之一,其原因是化疗耐药性高和血管生成不良,导致系统性治疗效果不佳。PDAC 的特征是肿瘤内压力高,而目前的 2D 和 3D 体外模型无法捕捉到这种压力。在这里,我们展示了一种 3D 微流控间质流模型,以模拟 PDAC 中的肿瘤内压力。我们发现,使 S2-028 PDAC 细胞系经受间质流会抑制其增殖,同时保持高活力。我们观察到吉西他滨化疗耐药性增加,与单层培养相比,EC50 几乎高出九倍 (31 nM 对 277 nM),并且多药耐药蛋白 (MRP) 家族的表达和功能减轻。总之,我们开发了一种用于研究组织内压力和流动的 3D 细胞培养方式,与传统的 2D 细胞培养相比,它具有更高的预测能力,并且比动物模型更省时、更具可扩展性和可及性。这种微生理相关性的提高可能有助于提高药物开发管道的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/2a13bb2a9b08/ijms-20-04647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/381fc3a8e163/ijms-20-04647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/9fc761c3735b/ijms-20-04647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/fd494cf7ce38/ijms-20-04647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/2a13bb2a9b08/ijms-20-04647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/381fc3a8e163/ijms-20-04647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/9fc761c3735b/ijms-20-04647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/fd494cf7ce38/ijms-20-04647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/961a/6770899/2a13bb2a9b08/ijms-20-04647-g004.jpg

相似文献

1
Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins.间质液通过诱导多药耐药蛋白在三维微流控胰腺导管腺癌模型中再现吉西他滨化疗耐药性。
Int J Mol Sci. 2019 Sep 19;20(18):4647. doi: 10.3390/ijms20184647.
2
Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.褪黑素通过消除核因子-κB激活克服胰腺导管腺癌中的吉西他滨耐药性。
J Pineal Res. 2016 Jan;60(1):27-38. doi: 10.1111/jpi.12285. Epub 2015 Oct 17.
3
TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.TM4SF1在体外和体内均可促进胰腺癌对吉西他滨的耐药性。
PLoS One. 2015 Dec 28;10(12):e0144969. doi: 10.1371/journal.pone.0144969. eCollection 2015.
4
HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1.HNF1A 抑制通过靶向 ABCB1 诱导胰腺癌细胞对吉西他滨的耐药性。
EBioMedicine. 2019 Jun;44:403-418. doi: 10.1016/j.ebiom.2019.05.013. Epub 2019 May 15.
5
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.RNA 结合蛋白 MEX3A 是胰腺导管腺癌对吉西他滨耐药的预后因素和调节因子。
Mol Oncol. 2021 Feb;15(2):579-595. doi: 10.1002/1878-0261.12847. Epub 2020 Nov 24.
6
Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.环巴胺逆转获得性化疗耐药并下调胰腺癌细胞系中的癌症干细胞标志物。
Swiss Med Wkly. 2011 May 31;141:w13208. doi: 10.4414/smw.2011.13208. eCollection 2011.
7
Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.辛伐他汀通过调节TGF-β1/Gfi-1轴减轻巨噬细胞介导的胰腺导管腺癌吉西他滨耐药性。
Cancer Lett. 2017 Jan 28;385:65-74. doi: 10.1016/j.canlet.2016.11.006. Epub 2016 Nov 11.
8
Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.胰腺癌细胞中STAT5b的抑制导致吉西他滨化疗耐药性、黏附及侵袭能力减弱。
Oncol Rep. 2016 Jun;35(6):3216-26. doi: 10.3892/or.2016.4727. Epub 2016 Apr 1.
9
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.人胰腺星状细胞分泌的纤连蛋白促进胰腺癌细胞对吉西他滨的化疗耐药性。
BMC Cancer. 2019 Jun 17;19(1):596. doi: 10.1186/s12885-019-5803-1.
10
Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma.CD36 对胰腺导管腺癌化疗耐药性的影响。
Ann Surg Oncol. 2020 Feb;27(2):610-619. doi: 10.1245/s10434-019-07927-2. Epub 2019 Oct 11.

引用本文的文献

1
Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy.用于胰腺导管腺癌光动力治疗的仿生肿瘤模型系统
Int J Mol Sci. 2025 Jul 2;26(13):6388. doi: 10.3390/ijms26136388.
2
Targeted Cancer Therapy-on-A-Chip.靶向癌症治疗芯片
Adv Healthc Mater. 2024 Nov;13(29):e2400833. doi: 10.1002/adhm.202400833. Epub 2024 Aug 5.
3
Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment.探索机械调节的肿瘤免疫微环境的创新方法

本文引用的文献

1
Competing tumor cell migration mechanisms caused by interstitial fluid flow.由组织间液流动引起的肿瘤细胞迁移竞争机制。
J Biomech. 2018 Nov 16;81:22-35. doi: 10.1016/j.jbiomech.2018.09.011. Epub 2018 Sep 17.
2
Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip.芯片上 3D 微流控肾近端小管中的药物转运体相互作用的筛选。
AAPS J. 2018 Jul 26;20(5):87. doi: 10.1208/s12248-018-0247-0.
3
Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer.
APL Bioeng. 2024 Feb 21;8(1):011501. doi: 10.1063/5.0183302. eCollection 2024 Mar.
4
Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R.患者特异性血管化肿瘤模型:用靶向CCR2和CSF-1R的多特异性抗体阻断肿瘤相关巨噬细胞招募
bioRxiv. 2023 Nov 29:2023.11.28.568627. doi: 10.1101/2023.11.28.568627.
5
Use and application of organ-on-a-chip platforms in cancer research.芯片器官平台在癌症研究中的应用
J Cell Commun Signal. 2023 Dec;17(4):1163-1179. doi: 10.1007/s12079-023-00790-7. Epub 2023 Nov 30.
6
A 3D Perfusable Platform for In Vitro Culture of Patient Derived Xenografts.用于患者来源异种移植物体外培养的 3D 可灌注平台。
Adv Healthc Mater. 2023 Jun;12(14):e2201434. doi: 10.1002/adhm.202201434. Epub 2023 Jan 8.
7
High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis.高通量 3D 微脉管芯片模型用于研究系统性硬化症中的血管生成缺陷。
Sci Rep. 2022 Oct 8;12(1):16930. doi: 10.1038/s41598-022-21468-x.
8
Perfusion in Organ-on-Chip Models and Its Applicability to the Replication of Spermatogenesis In Vitro.器官芯片模型中的灌注及其在体外复制精子发生中的适用性。
Int J Mol Sci. 2022 May 12;23(10):5402. doi: 10.3390/ijms23105402.
9
Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review.用于肿瘤细胞药物筛选和递送的芯片器官平台:一项系统综述
Cancers (Basel). 2022 Feb 13;14(4):935. doi: 10.3390/cancers14040935.
10
The biophysics of cancer: emerging insights from micro- and nanoscale tools.癌症生物物理学:来自微米和纳米尺度工具的新见解
Adv Nanobiomed Res. 2022 Jan;2(1). doi: 10.1002/anbr.202100056. Epub 2021 Nov 23.
采用高分辨率熔解曲线分析技术动态定量检测ABC转运蛋白家族启动子甲基化以预测胰腺癌的多药耐药性
Oncol Lett. 2018 Apr;15(4):5602-5610. doi: 10.3892/ol.2018.8041. Epub 2018 Feb 13.
4
Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?处于 2D 与动物模型之间:3D 培养物是否是研究癌症-微环境相互作用的理想工具?
Int J Mol Sci. 2018 Jan 18;19(1):181. doi: 10.3390/ijms19010181.
5
Pancreatic Cancer Chemoresistance to Gemcitabine.胰腺癌对吉西他滨的化疗耐药性
Cancers (Basel). 2017 Nov 16;9(11):157. doi: 10.3390/cancers9110157.
6
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.在 3D 高通量灌注微流控平台中对乳腺癌的治疗反应进行测试。
BMC Cancer. 2017 Nov 2;17(1):709. doi: 10.1186/s12885-017-3709-3.
7
Three-Dimensional Cell Cultures in Drug Discovery and Development.三维细胞培养在药物发现和开发中的应用。
SLAS Discov. 2017 Jun;22(5):456-472. doi: 10.1177/1087057117696795.
8
High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform.在微流控平台上的神经元和神经胶质的 3D 网络上进行高通量化合物评估。
Sci Rep. 2016 Dec 9;6:38856. doi: 10.1038/srep38856.
9
Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.芯片肾技术用于药物诱导的肾毒性筛选。
Trends Biotechnol. 2016 Feb;34(2):156-170. doi: 10.1016/j.tibtech.2015.11.001. Epub 2015 Dec 18.
10
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.微小RNA分析揭示了突变型p53胰腺导管腺癌中吉西他滨化疗耐药的新标志物。
PLoS One. 2015 Nov 25;10(11):e0143755. doi: 10.1371/journal.pone.0143755. eCollection 2015.